Otsuka Pakistan Limited (PSX:OTSU)

Pakistan · Delayed Price · Currency is PKR

366.55

-8.89 (-2.37%)

At close: Sep 8, 2026

Market Cap	4.36B +20.2%
Revenue (ttm)	4.11B +8.8%
Net Income	472.13M +1,605.8%
EPS	39.02 +1,605.9%
Shares Out	12.10M
PE Ratio	9.24
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,557
Open	370.00
Previous Close	375.44
Day's Range	364.01 - 374.00
52-Week Range	261.00 - 456.46
Beta	0.80
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 2, 2026

About Otsuka Pakistan

Otsuka Pakistan Limited manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan. The company offers intravenous solutions, including electrolyte and standard solutions, ampoules, OTSUZOL, and ciprofloxacin and OTSUMOL infusion products; medical devices, such as urea breath test systems, plasline solutions, clinical nutrition products comprising aminoleban oral, aminovel 600, pan-amin G, aminoleban injection, fatolip, and proten gold; and therapeutic drugs, which include pletaal and mucosta tablets, as well as or... [Read more]

Industry Pharmaceuticals

Sector Healthcare

Founded 1988

Employees 408

Stock Exchange Pakistan Stock Exchange

Ticker Symbol OTSU

Full Company Profile

Financial Performance

In fiscal year 2026, Otsuka Pakistan's revenue was 4.11 billion, an increase of 8.77% compared to the previous year's 3.78 billion. Earnings were 472.13 million, an increase of 1605.84%.

Financial Statements